“Cardiovascular Risk With Gender‑Affirming Hormone Therapy”. Canadian Diabetes & Endocrinology Today, vol. 4, no. 2, Aug. 2026, pp. 34–40, https://doi.org/10.58931/cdet.2026.4258.